149 related articles for article (PubMed ID: 38598024)
1. Elevated serum 25-hydroxyvitamin D: a potential indicator of remission in Takayasu arteritis patients with normal ESR and CRP levels.
Liao H; Du J; Li F; Yang S; Qi G; Pan L
Clin Rheumatol; 2024 Jun; 43(6):1979-1987. PubMed ID: 38598024
[TBL] [Abstract][Full Text] [Related]
2. Development and initial validation of the Indian Takayasu Clinical Activity Score (ITAS2010).
Misra R; Danda D; Rajappa SM; Ghosh A; Gupta R; Mahendranath KM; Jeyaseelan L; Lawrence A; Bacon PA;
Rheumatology (Oxford); 2013 Oct; 52(10):1795-801. PubMed ID: 23594468
[TBL] [Abstract][Full Text] [Related]
3. Infliximab biosimilar CT-P13 therapy in patients with Takayasu arteritis with low dose of glucocorticoids: a prospective single-arm study.
Park EH; Lee EY; Lee YJ; Ha YJ; Yoo WH; Choi BY; Paeng JC; Suh HY; Song YW
Rheumatol Int; 2018 Dec; 38(12):2233-2242. PubMed ID: 30229280
[TBL] [Abstract][Full Text] [Related]
4. Serum cytokine profiles in Takayasu's arteritis: search for biomarkers.
Alibaz-Oner F; Yentür SP; Saruhan-Direskeneli G; Direskeneli H
Clin Exp Rheumatol; 2015; 33(2 Suppl 89):S-32-5. PubMed ID: 25436391
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcome of 251 patients with Takayasu arteritis on combination immunosuppressant therapy: Single centre experience from a large tertiary care teaching hospital in Southern India.
Goel R; Danda D; Joseph G; Ravindran R; Kumar S; Jayaseelan V; Jayaseelan L; Bacon P
Semin Arthritis Rheum; 2018 Apr; 47(5):718-726. PubMed ID: 29096935
[TBL] [Abstract][Full Text] [Related]
6. The C-Reactive Protein/Albumin Ratio and Complete Blood Count Parameters as Indicators of Disease Activity in Patients with Takayasu Arteritis.
Seringec Akkececi N; Yildirim Cetin G; Gogebakan H; Acipayam C
Med Sci Monit; 2019 Feb; 25():1401-1409. PubMed ID: 30792377
[TBL] [Abstract][Full Text] [Related]
7. Platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio associated with disease activity in patients with Takayasu's arteritis: a case-control study.
Pan L; Du J; Li T; Liao H
BMJ Open; 2017 May; 7(4):e014451. PubMed ID: 28473512
[TBL] [Abstract][Full Text] [Related]
8. Profiles of serum cytokine levels in Takayasu arteritis patients: Potential utility as biomarkers for monitoring disease activity.
Tamura N; Maejima Y; Tezuka D; Takamura C; Yoshikawa S; Ashikaga T; Hirao K; Isobe M
J Cardiol; 2017 Sep; 70(3):278-285. PubMed ID: 27989502
[TBL] [Abstract][Full Text] [Related]
9. Analysis of predictive factors for treatment resistance and disease relapse in Takayasu's arteritis.
Sun Y; Ma L; Chen H; Kong X; Lv P; Dai X; Ji Z; Yang C; Dai S; Wu L; Zou Y; Lin J; Shi H; Yu Q; Jiang L
Clin Rheumatol; 2018 Oct; 37(10):2789-2795. PubMed ID: 29687289
[TBL] [Abstract][Full Text] [Related]
10. Tocilizumab treatment effectively improves coronary artery involvement in patients with Takayasu arteritis.
Pan L; Du J; Liu J; Liao H; Liu X; Guo X; Liang J; Han H; Yang L; Zhou Y
Clin Rheumatol; 2020 Aug; 39(8):2369-2378. PubMed ID: 32144625
[TBL] [Abstract][Full Text] [Related]
11. Serum amyloid A as a marker of disease activity and treatment response in Takayasu arteritis.
Nair AM; Goel R; Hindhumati M; Jayakanthan K; Visalakshi J; Joseph G; Danda S; Danda D
Rheumatol Int; 2017 Oct; 37(10):1643-1649. PubMed ID: 28801814
[TBL] [Abstract][Full Text] [Related]
12. Elevated serum immunoglobulin level predicts high risk of 1-year recurrence in patients with Takayasu arteritis.
Guo Y; Du J; Li T; Gao N; Yang S; Zhang Y; Pan L
Arthritis Res Ther; 2023 Mar; 25(1):36. PubMed ID: 36882846
[TBL] [Abstract][Full Text] [Related]
13. Brachial-Ankle Pulse Wave Velocity is Increased and Associated with Disease Activity in Patients with Takayasu Arteritis.
Wang Z; Dang A; Lv N
J Atheroscler Thromb; 2020 Feb; 27(2):172-182. PubMed ID: 31270281
[TBL] [Abstract][Full Text] [Related]
14. Serum BAFF and APRIL levels in Indian patients with Takayasu arteritis.
Zanwar A; Jain A; Gupta L; Chaurasia S; Kumar S; Misra DP; Misra R
Clin Rheumatol; 2018 Dec; 37(12):3439-3442. PubMed ID: 29998368
[TBL] [Abstract][Full Text] [Related]
15. The role of plateletcrit in Takayasu arteritis: A potential biomarker for disease activity and 6-month treatment response.
Sun Y; Cui X; Kong X; Chen H; Wu S; Ma L; Ding Z; Jiang L
Int J Rheum Dis; 2023 Dec; 26(12):2517-2525. PubMed ID: 37875306
[TBL] [Abstract][Full Text] [Related]
16. Potential Role of Macrophage Phenotypes and CCL2 in the Pathogenesis of Takayasu Arteritis.
Kong X; Xu M; Cui X; Ma L; Cheng H; Hou J; Sun X; Ma L; Jiang L
Front Immunol; 2021; 12():646516. PubMed ID: 34079541
[TBL] [Abstract][Full Text] [Related]
17. Are monocyte-to-HDL and C-reactive protein-to-albumin ratios useful for the diagnosis and follow-up of Takayasu arteritis?
Kılınç EA; Varkal G; Kırmızıer G; Türk İ; Özer HTE
Rev Assoc Med Bras (1992); 2024; 70(5):e20231683. PubMed ID: 38775535
[TBL] [Abstract][Full Text] [Related]
18. Performance of the PET vascular activity score (PETVAS) for qualitative and quantitative assessment of inflammatory activity in Takayasu's arteritis patients.
Kang F; Han Q; Zhou X; Zheng Z; Wang S; Ma W; Zhang K; Quan Z; Yang W; Wang J; Zhu P
Eur J Nucl Med Mol Imaging; 2020 Dec; 47(13):3107-3117. PubMed ID: 32567005
[TBL] [Abstract][Full Text] [Related]
19. Anaemia can be improved by controlling the disease activity of Takayasu's arteritis without iron administration.
Guo Y; Du J; Li T; Gao N; Pan L
Int J Lab Hematol; 2023 Feb; 45(1):112-118. PubMed ID: 36117441
[TBL] [Abstract][Full Text] [Related]
20. The role of mean platelet volume in patients with Takayasu arteritis.
Peng YF; Guo J; Deng YB
Ann Clin Biochem; 2017 Mar; 54(2):273-278. PubMed ID: 27329216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
